COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
Health care providers participating in the Centers for Disease Control and Prevention’s COVID-19 Vaccination Program must administer the vaccines at no cost to recipients, the Department of Health and Human Services reminded providers and health plans in a letter.
The Food and Drug Administration is warning health care providers and the public not to use two COVID-19 antigen and antibody tests, due to high risk of false results.
The Centers for Medicare & Medicaid Services May 28 issued a new informational bulletin on COVID-19 vaccines for adolescents ages 12 and older, which addresses access and eligibility, along with information on patient outreach and education.
Moderna asked the Food and Drug Administration to grant full approval of its COVID-19 vaccine for people age 18 years and older.
The Centers for Disease Control and Prevention recommended clinicians report all cases of inflammation of the heart muscle (myocarditis) or lining (pericarditis) after COVID-19 vaccination to the Vaccine Adverse Event Reporting System, citing an increase since April in cases reported after…
FDA issues reminder on need for clear nasal sampling instructions; dogs detect COVID-19 in body odor
The Food and Drug Administration reminded health care providers to give patients who self-collect anterior nasal samples for SARS-CoV-2 testing in health care settings step-by-step instructions.
The Food and Drug Administration authorized storing thawed, undiluted vials of the Pfizer COVID-19 vaccine at refrigerator temperatures (35°F to 46°F) for up to 30 days after the company submitted data showing the vials can remain stable that long, up from the previously authorized five days.
COVID-19 vaccination coverage was about 7 percentage points lower in rural counties than in urban counties as of April 10, the Centers for Disease Control and Prevention reported today.
The Food and Drug Administration updated its emergency use authorizations for two intravenous infusion therapies for outpatients at risk for progressing to severe COVID-19 disease.
The Centers for Disease Control and Prevention emphasized that its new masking recommendations for people fully vaccinated against COVID-19 do not apply to health care settings.